### Summary Outcome (Data)
1. **Numbers**: N=852 (Panel, 2 periods). Pre-Trend Placebo (1991): β=+0.45 (SE=0.38, p=0.125). Post-Trend DiD (1999): β=-7.26 (SE=2.10, p=0.0006). ANCOVA R²=0.831.
2. **What it Proves**: Causality via Parallel Trends. The interaction effect was zero before treatment (validating the counterfactual) and spiked only after rollout. This rules out pre-existing divergent trends.
3. **What Still Needs Proving**: Robustness to outliers and alternative functional forms (addressed in Project 5).

---

### Detailed Sequential Analysis

**Step 1: Placebo Test (1991 Data) (`Step1_Placebo_Test.csv`)**
- **Data**: 
  - Fake Treatment Interaction (1991): β=+0.45 (p=0.125).
  - Confidence Interval includes 0 comfortably.
- **Inference**: No pre-trend. High-agency and low-agency districts were moving in parallel before EVMs arrived.

**Step 2: DiD Estimation (`Step2_DiD_Estimation.csv`)**
- **Data**: 
  - DiD Coefficient: β=-7.26 (SE=2.10, p=0.0006).
  - Fixed Effects: District + Year included.
- **Inference**: The "penalty" emerges strictly in the post-treatment period. The magnitude (-7.26) is consistent with the cross-sectional interaction in Project 3.

**Step 3: ANCOVA Specification (`Step3_ANCOVA_Results.csv`)**
- **Data**: 
  - Coefficient on Baseline Turnout: β=0.88 (p<0.001).
  - Adjusted Treatment Effect: β=-6.95 (p=0.0009).
  - R²=0.831 (highest so far).
- **Inference**: Controlling for baseline outcomes increases precision. The result holds firm.

**Visualizations**
- `parallel_trends_plot.png`: Coefficient plot over time (or pre/post). The pre-period dot is on zero; the post-period dot is significantly negative. Visual confirmation of the "break" in trends.
- `placebo_distribution.png`: Histogram of placebo coefficients from permutation tests. The actual observed coefficient falls far in the tail, while the placebo distribution centers on zero.
